Variability of the hepatitis C virus genome

Current Studies in Hematology and Blood Transfusion

Volumn 62, Issue , 1998, Pages 38-63

  Simmonds, Peter ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; VIRUS RNA;

AMINO ACID SEQUENCE; ANTIVIRAL ACTIVITY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PERSISTENT VIRUS INFECTION; PHYLOGENY; PRIORITY JOURNAL; REVIEW; SERODIAGNOSIS; VIRAL GENETICS; VIRUS GENOME; VIRUS ISOLATION;

ANIMALS; DISEASE PROGRESSION; EVOLUTION; GENOME, VIRAL; GENOTYPE; HEPACIVIRUS; HUMANS; SEQUENCE ANALYSIS, RNA; VARIATION (GENETICS); VIRAL HEPATITIS VACCINES;

EID: 0031883906     PISSN: 02580330     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000060468     Document Type: Article

References (131)

1. Collett MS, Anderson DK, Retzel E: Comparisons of the pestivirus bovine viral diarrhoea virus with members of the Flaviviridae. J Gen Virol 1988;69:2637-2643.
2. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, Desai SM, Mushahwar IK: Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995;1:564-569.
3. Leary TP, Muerhoff AS, Simons JN, Pilot-Matias TJ, Erker JC, Chalmers ML, Schlauder GG, Dawson GJ, Dessai SM, Mushahwar IK: Sequence and genomic organization of GBV-C: A novel member of the Flaviviridae associated with human non-A-E hepatitis. J Med Virol 1996;48:60-67.
4. Linnen J, Wages J, ZhangKeck ZY, Fry KE, Krawczynski KZ, Alter H, Koonin E, Gallagher M, Alter M, Hadziyannis S, Karayiannis P, Fung K, Nakatsuji Y, Shih JWK, Young L, Piatak M, Hoover C, Fernandez J, Chen S, Zou JC, Morris T, Hyams KC, Ismay S, Lifson JD, Hess G, Foung SKH, Thomas H, Bradley D, Margolis H, Kim JP: Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent. Science 1996;271:505-508.
5. Simons JN, Pilot-Matias TJ, Leary TP, Dawson GJ, Desai SM, Schlauder GG, Muerhoff AS, Erker JC, Buijk SL, Chalmers ML, Vansant CL, Mushahwar IK: Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA 1995;92:3401-3405.
6. Tsukiyama Kohara K, Iizuka N, Kohara M, Nomoto A: Internal ribosome entry site within hepatitis C virus RNA. J Virol 1992;66:1476-1483.
7. Simmonds P, McOmish F, Yap PL, Chan SW, Lin CK, Dusheiko G, Saeed AA, Holmes EC: Sequence variability in the 5′ non-coding region of hepatitis C virus: Identification of a new virus type and restrictions on sequence diversity. J Gen Virol 1993;74:661-668.
8. Wang CY, Sarnow P, Siddiqui A: A conserved helical element is essential for internal initiation of translation of hepatitis C virus RNA. J Virol 1994;68:7301-7307.
9. Poole TL, Wang CY, Popp RA, Potgieter LND, Siddiqui A, Marc S: Pestivirus translation initiation occurs by internal ribosome entry. Virology 1995;206:750-754.
10. Simons JN, Desai SM, Schultz DE, Lemon SM, Mushahwar IK: Translation initiation in GB viruses A and C: Evidence for internal ribosome entry and implications for genome organisation. J Virol 1996;70:6126-6135.
11. Miller RH, Purcell RH: Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc Natl Acad Sci USA 1990; 87:2057-2061.
12. Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina Selby R, Barr PJ, Weiner AJ, Bradley DW, Kuo G, Houghton M: Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 1991;88:2451-2455.
13. Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T, Shimotohno K: Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA 1990;87:9524-9528.
14. Takamizawa A, Mori C, Fuke I, Manabe S, Murakami S, Fujita J, Onishi E, Andoh T, Yoshida I, Okayama H: Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol 1991;65:1105-1113.
15. Okamoto H, Kurai K, Okada S, Yamamoto K, Lizuka H, Tanaka T, Fukuda S, Tsuda F, Mishiro S: Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: Comparative study of four distinct genotypes. Virology 1992;188:331-341.
16. Okamoto H, Okada S, Sugiyama Y, Kurai K, Iizuka H, Machida A, Miyakawa Y, Mayumi M: Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: Comparison with reported isolates for conserved and divergent regions. J Gen Virol 1991;72:2697-2704.
17. Mori S, Kato N, Yagyu A, Tanaka T, Ikeda Y, Petchclai B, Chiewsilp P, Kurimura T, Shimotohno K: A new type of hepatitis C virus in patients in Thailand. Biochem Biophys Res Comun 1992; 183:334-342.
18. Chan S-W, McOmish F, Holmes EC, Dow B, Peutherer JF, Follett E, Yap PL, Simmonds P: Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol 1992;73:1131-1141.
19. Bukh J, Purcell RH, Miller RH: At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proc Natl Acad Sci USA 1993;90: 8234-8238.
20. Bhattacherjee V, Prescott LE, Pike I, Rodgers B, Bell H, Elzayadi AR, Kew MC, Conradie J, Lin CK, Marsden H, Saeed AA, Parker D, Yap PL, Simmonds P: Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6. J Gen Virol 1995;76:1737-1748.
21. Bukh J, Purcell RH, Miller RH: Sequence analysis of the core gene of 14 hepatitis C virus genotypes. Proc Natl Acad Sci USA 1994;91:8239-8243.
22. Enomoto N, Takada A, Nakao T, Date T: There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Commun 1990;170:1021-1025.
23. Simmonds P, Holmes EC, Cha TA, Chan S-W, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS: Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993;74:2391-2399.
24. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechet C, Brouwer JT, Chan SW, Chayama K, Chen DS, Choo QL, Colombo M, Cuypers HTM, Date T, Dusheiko GM, Esteban JI, Fay O, Hadziyannis SJ, Han J, Hatzakis A, Holmes EC, Hotta H, Houghton M, Irvine B, Kohara M, Kolberg JA, Kuo G, Lau JYN, Lelie PN, Maertens G, McOmish F, Miyamura T, Mizokami M, Nomoto A, Prince AM, Reesink HW, Rice C, Roggendorf M, Schalm SW, Shikata T, Shimotohno K, Stuyver L, Trepo C, Weiner A, Yap PL, Urdea MS: A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994;19:1321-1324.
25. Stuyver L, Vanarnhem W, Wyseur A, Hernandez F, Delaporte E, Maertens G: Classification of hepatitis C viruses based on phylogenetic analysis of the envelope 1 and nonstructural 5b regions and identification of five additional subtypes. Proc Natl Acad Sci USA 1994;91:10134-10138.
26. Mellor J, Holmes EC, Jarvis LM, Yap PL, Simmonds P, International Collaborators: Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: Implications for virus classification. J Gen Virol 1995;76:2493-2507.
27. Tokita H, Okamoto H, Iizuka H, Kishimoto J, Tsuda F, Lesmana LA, Miyakawa Y, Mayumi M: Hepatitis C virus variants from Jakarta, Indonesia classifiable into novel genotypes in the second (2e and 2f), tenth (10a) and eleventh (11a) genetic groups. J Gen Virol 1996;77:293-301.
28. Simmonds P, Mellor J, Holmes EC, Tamprasert S, Sakuldamrongpanich T, Nuchaprayoon C, Smith DB: Evolutionary analysis of variants of hepatitis C virus found in South East Asia: Comparison with classifications based upon sequence similarity. J Gen Virol, in press.
29. McOmish F, Chan S-W, Dow BC, Gillon J, Frame WD, Crawford RJ, Yap PL, Follett EAC, Simmonds P: Detection of three types of hepatitis C virus in blood donors: Investigation of type-specific differences in serological reactivity and rate of alanine aminotransferase abnormalities. Transfusion 1993;33:7-13.
30. Goeser T, Tox U, Muller HM, Arnold JC, Theilmann L: Genotypes in chronic hepatitis C virus (HCV) infection and in liver cirrhosis caused by HCV in Germany. Dtsch Med Wochenschr 1995; 120:1070-1073.
31. Pawlotsky JM, Tsakiris L, Roudotthoraval F, Pellet C, Stuyver L, Duval J, Dhumeaux D: Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 1995;171:1607-1610.
32. Tisminetzky SG, Gerotto M, Pontisso P, Chemello L, Ruvoletto MG, Baralle F, Alberti A: Genotypes of hepatitis C virus in Italian patients with chronic hepatitis C. Int Hepatol Commun 1994;2:105-112.
33. Lau JYN, Davis GL, Prescott LE, Maertens G, Lindsay KL, Qian KP, Mizokami M, Simmonds P, Perrillo RP, Schiff ER, Bodenheimer HC, Balart LA, Regenstein F, Dienstag JL, Katkov WN, Tamburro CH, Goff JS, Everson GT, Goodman Z, Albrecht J: Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Ann Intern Med 1996;124:868.
34. Simmonds P, Mellor J, Craxi A, Sancheztapias JM, Alberti A, Prieto J, Colombo M, Rumi MG, LoIacano O, Ampurdanes Mingall S, Forns Bernhardt X, Chemello L, Civeira MP, Frost C, Dusheiko G: Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients. J Hepatol 1996;24:517-524.
35. Saeed AA, al Admawi AM, al Rasheed A, Fairclough D, Bacchus R, Ring C, Garson J: Hepatitis C virus infection in Egyptian volunteer blood donors in Riyadh. Lancet 1991;338:459-460.
36. Darwish MA, Raouf TA, Rushdy P, Constantine NT, Rao MR, Edelman R: Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am J Trop Med Hyg 1993;49:440-447.
37. Kamel MA, Ghaffar YA, Wasef MA, Wright M, Clark LC, Miller FD: High HCV prevalence in Egyptian blood donors. Lancet 1992;340:427.
38. McOmish F, Yap PL, Dow BC, Follett EAC, Seed C, Keller AJ, Cobain TJ, Krusius T, Kolho E, Naukkarinen R, Lin C, Lai C, Leong S, Medgyesi GA, Hejjas M, Kiyokawa H, Fukada K, Cuypers T, Saeed AA, Alrasheed AM, Lin M, Simmonds P: Geographical distribution of hepatitis C virus genotypes in blood donors - An international collaborative survey. J Clin Microbiol 1994;32:884-892.
39. Tokita H, Okamoto H, Tsuda F, Song P, Nakata S, Chosa T, Iizuka H, Mishiro S, Miyakawa Y, Mayumi M: Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups. Proc Natl Acad Sci USA 1994;91:11022-11026.
40. Tokita H, Okamoto H, Luengrojanakul P, Vareesangthip K, Chainuvati T, Iizuka H, Tsuda F, Miyakawa Y, Mayumi M: Hepatitis C virus variants from Thailand classifiable into five novel genotypes in the sixth (6b), seventh (7c, 7d) and ninth (9b, 9c) major genetic groups. J Gen Virol 1995;76:2329-2335.
41. Apichartpiyakul C, Chittivudikarn C, Miyajima H, Homma M, Hotta H: Analysis of hepatitis C virus isolates among healthy blood donors and drug addicts in Chiang Mai, Thailand. J Clin Microbiol 1994;32:2276-2279.
42. Okamoto H, Kojima M, Okada S-I, Yoshizawa H, Iizuka H, Tanaka T, Muchmore EE, Ito Y, Mishiro S: Genetic drift of hepatitis C virus during an 8.2 year infection in a chimpanzee: Variability and stability. Virology 1992;190:894-899.
43. Ogata N, Alter HJ, Miller RH, Purcell RH: Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci USA 1991;88:3392-3396.
44. Power JP, Lawlor E, Davidson F, Yap PL, Kenny-Walsh E, Whelton MJ, Walsh TJ: Hepatitis C viraemia in recipients of Irish intravenous anti-D immunoglobulin. Lancet 1994;344:1166-1167.
45. Power JP, Lawlor E, Davidson F, Holmes EC, Yap PL, Simmonds P: Molecular epidemilogy of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet 1995; 345:1211-1213.
46. Smith DB, Pathirana S, Davidson F, Lawlor E, Power J, Yap PL, Simmonds P: The origin of hepatitis C virus genotypes. J Gen Virol 1997;78:321-328.
47. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M: Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. J Gen Virol 1992;73:673-679.
48. Okamoto H, Tokita H, Sakamoto M, Horikita M, Kojima M, Iizuka M, Mishiro S: Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol 1993;74:2385-2390.
49. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, Maertens G: Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993;74:1093-1102.
50. Davidson F, Simmonds P, Ferguson JC, Jarvis LM, Dow BC, Follett EAC, Seed CRG, Krusius T, Lin C, Medgyesi GA, Kiyokawa H, Olim G, Duraisamy G, Cuypers T, Saeed AA, Teo D, Conradie J, Kew MC, Lin M, Nuchaprayoon C, Ndimbie OK, Yap PL: Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non-coding region. J Gen Virol 1995;76:1197-1204.
51. Simmonds P, Rose KA, Graham S, Chan SW, McOmish F, Dow BC, Follett EAC, Yap PL, Marsden H: Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV) - Use of type-specific peptides to serologically differentiate infections with HCV type 1, type 2, and type 3. J Clin Microbiol 1993;31:1493-1503.
52. Tanaka T, Tsukiyamakohara K, Yamaguchi K, Yagi S, Tanaka S, Hasegawa A, Ohta Y, Hattori N, Kohara M: Significnce of specific antibody assay for genotyping of hepatitis C virus. Hepatology 1994;19:1347-1353.
53. Lau JYN, Mizokami M, Kolberg JA, Davis GL, Prescott LE, Ohno T, Perrillo RP, Lindsay KL, Gish RG, Qian KP, Kohara M, Simmonds P, Urdea MS: Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J Infect Dis 1995; 171:281-289.
54. Martell M, Esteban JI, Quer J, Genesca J, Weiner A, Esteban R, Guardia J, Gomez J: Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: Quasispecies nature of HCV genome distribution. J Virol 1992;66:3225-3229.
55. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, Crawford K, Marion CD, Crawford KA, et al: Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: Potential role in chronic HCV infections. Proc Natl Acad Sci USA 1992;89:3468-3472.
56. Kurosaki M, Enomoto N, Marumo F, Sato C: Evolution and selection of hepatitis C virus variants in patients with chronic hepatitis C. Virology 1994;205:161-169.
57. Duarte EA, Novella IS, Ledesma S, Clarke DK, Moya A, Elena SF, Domingo E, Holland JJ: Subclonal components of consensus fitness in an RNA virus clone. J Virol 1994;68:4295-4301.
58. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Ohkoshi S, Shimotohno K: Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun 1991;175:220-228.
59. Kato N, Ootsuyama Y, Tanaka T, Nakagawa M, Nakazawa T, Muraiso K, Ohkoshi S, Hijikata M, Shimotohno K: Marked sequence diversity in the putative envelope proteins of hepatitis C viruses. Virus Res 1992;22:107-123.
60. Weiner A, Erickson AL, Kansopon J, Crawford K, Muchmore E, Hughes AL, Houghton M, Walker CM: Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc Natl Acad Sci USA 1995;92:2755-2759.
61. Kurosaki M, Enomoto N, Marumo F, Sato C: Variations in the core region of hepatitis C virus genomes in patients with chronic hepatitis. Arch Virol 1995;140:1087-1094.
62. Prince AM, Brotman B, Huima T, Pascual D, Jaffery M, Inchauspe G: Immunity in hepatitis C infection. J Infect Dis 1992;165:438-443.
63. Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, Desai SM, Miller RH, Ogata N, Purcell RH: Lack of protective immunity against reinfection with hepatitis C virus. Science 1992;258:135-140.
64. Lai ME, Mazzoleni AP, Argiolu F, De Virgilis S, Balestriesi A, Purcell RH, Cao A, Farci P: Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 1994; 343:388-390.
65. Kato N, Sekiya H, Ootsuyama Y, Nakazawa T, Hijikata M, Ohkoshi S, Shimotohno K: Humoral immune response to hypervariable region-1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol 1993;67:3923-3930.
66. Lesniewski RR, Boardway KM, Casey JM, Desai SM, Devare SG, Leung TK, Mushahwar IK: Hypervariable 5′-terminus of hepatitis C virus E2/NS1 encodes antigenically distinct variants. J Med Virol 1993;40:150-156.
67. Taniguchi S, Okamoto H, Sakamoto M, Kojima M, Tsuda F, Tanaka T, Munekata E, Muchmore EE, Peterson DA, Mishiro S: A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein - Implication for an escape from antibody. Virology 1993;195:297-301.
68. Kumar U, Monjardino J, Thomas HC: Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient. Gastroenterology 1994;106:1072-1075.
69. Vandoorn LJ, Capriles I, Maertens G, Deleys R, Murray K, Kos T, Schellekens H, Quint W: Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses. J Virol 1995;69:773-778.
70. Okada S-I, Akahane Y, Suzuki H, Okamoto H, Mishiro S: The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viraemic patients. Hepatology 1992;16:619-624.
71. Kumar U, Brown J, Monjardino J, Thomas HC: Sequence variation in the large envelope glycoprotein (E2/NS1) of hepatitis C virus during chronic infection. J Infect Dis 1993;167:726-730.
72. Higashi Y, Kakumu S, Yoshioka K, Wakita T, Mizokami M, Ohba K, Ito Y, Ishikawa T, Takayanagi M, Nagai Y: Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology 1993;197:659-668.
73. Nakazawa T, Kato N, Fujioka T, Shibuya A, Shimotohno K: Humoral immune response to hypervariable region 1 of a hepatitis C viral envelope glycoprotein (gp70) obtained from an asymptomatic carrier. Int Hepatol Commun 1995;3:77-81.
74. Scarselli E, Cerino A, Esposito G, Silini E, Mondelli MU, Traboni C: Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients. J Virol 1995;69:4407-4412.
75. Sherman KE, Andreatta C, Obrien J, Gutierrez A, Harris R: Hepatitis C in human immunodeficiency virus-coinfected patients: Increased variability in the hypervariable envelope coding domain. Hepatology 1996;23:688-694.
76. Enomoto N, Kurosaki M, Tanaka Y, Marumo F, Sato C: Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis. J Gen Virol 1994;75:1361-1369.
77. Naito M, Hayashi N, Moribe T, Hagiwara H, Mita E, Kanazawa Y, Kasahara A, Fusamoto H, Kamada T: Hepatitis C viral quasispecies in hepatitis C virus carriers with normal liver enzymes and patients with type C chronic liver disease. Hepatology 1995;22:407-412.
78. Kurosaki M, Enomoto N, Marumo F, Sato C: Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection. Hepatology 1993;18:1293-1299.
79. Kao JH, Chen PJ, Lai MY, Wang TH, Chen DS: Quasispecies of hepatitis C virus and genetic drift of the hypervariable region in chronic type C hepatitis. J Infect Dis 1995;172:261-264.
80. Chien DY, Choo QL, Ralston R, Spaete R, Tong M, Houghton M, Kuo G: Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet 1993;342:933.
81. Hada H, Koide N, Hanafusa T, Sakaguchi K, Shinji T, Sasaki S, Oka T, Takayama N, Yumoto Y, Tsuji T: Detection by Western blotting of an antibody to the hepatitis C virus E1 envelope protein in sera of patients with chronic liver disease. Acta Med Okayama 1992;46:365-370.
82. Rosa D, Campagnoli S, Moretto C, Guenzi E, Cousens L, Chin M, Dong C, Weiner AJ, Lau JYN, Choo QL, Chien D, Pileri P, Houghton M, Abrignani S: A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci USA 1996;93:1759-1763.
83. Zibert A, Schreier E, Roggendorf M: Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 1995;208:653-661.
84. Miyamoto H, Okamoto H, Sato K, Tanaka T, Mishiro S: Extraordinarily low density of hepatitis C virus estimated by sucrose density gradient centrifugation and the polymerase chain reaction. J Gen Virol 1992;73:715-718.
85. Thomssen R, Bonk S, Thiele A: Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins. Med Microbiol Immunol 1993;182:329-334.
86. Weiner AJ, Thaler MM, Crawford K, Ching K, Kansopon J, Chien DY, Hall JE, Hu F, Houghton M: A unique, predominant hepatitis C virus variant found in an infant born to a mother with multiple variants. J Virol 1993;67:4365-4368.
87. Honda M, Kaneko S, Unoura M, Kobayashi K, Murakami S: Risk of hepatitis C virus infections through household contact with chronic carriers - Analysis of nucleotide sequences. Hepatology 1993;17:971-976.
88. Rice PS, Smith DB, Simmonds P, Holmes E: Heterosexual transmission of hepatitis C virus. Lancet 1993;342:1052-1053.
89. Setoguchi Y, Kajihara S, Hara T, Motomura M, Mizuta T, Wada I, Yamamoto K, Sakai T: Analysis of nucleotide sequences of hepatitis C virus isolates from husband-wife pairs. J Gastroenterol Hepatol 1994;9:468-471.
90. Healey CJ, Smith DB, Walker JL, Holmes EC, Fleming KA, Chapman RWG, Simmonds P: Acute hepatitis C infection after sexual exposure. Gut 1995;36:148-150.
91. Healey CJ, Sabharwal NK, Daub J, Davidson F, Yap PL, Fleming KA, Chapman RWG, Simmonds P, Chapel H: Outbreak of acute hepatitis C following the use of anti-hepatitis C virus - Screened intravenous immunoglobulin therapy. Gastroenterology 1996;110:1120-1126.
92. Echevarria JM, Leon P, Domingo CJ, Lopez JA, Elola C, Madurga M, Salmeron F, Yap PL, Simmonds P: Laboratory diagnosis and molecular epidemiology of an outbreak of hepatitis C virus infection among recipients of a human intravenous immunoglobulin in Spain. Transfusion 1996; 76:725-730.
93. Pawlotsky JM, Roudotthoraval F, Pellet C, Aumont P, Darthuy F, Remire J, Duval J, Dhumeaux D: Influence of hepatitis C virus (HCV) genotypes on HCV recombinant immunoblot assay patterns. J Clin Microbiol 1995;33:1357-1359.
94. Dhaliwal SK, Prescott LE, Dow BC, Davidson F, Brown H, Yap PL, Follett EAC, Simmonds P: Influence of viraemia and genotype upon serological reactivity in screening assays for antibody to hepatitis C virus. J Med Virol 1996;48:184-190.
95. Choo QL, Kuo G, Ralston R, Weiner A, Chien D, Vannest G, Han J, Berger K, Thudium K, Kuo C, Kansopon J, Mcfarland J, Tabrizi A, Ching K, Moss B, Cummins LB, Houghton M, Muchmore E: Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci USA 1994;91:1294-1298.
96. Mita E, Hayashi N, Kanazawa Y, Hagiwara H, Ueda K, Kasahara A, Fusamoto H, Kamada T: Hepatitis C virus genotype and RNA titer in the progression of type C chronic liver disease. J Hepatol 1994;21:468-473.
97. Yamada M, Kakumu S, Yoshioka K, Higashi Y, Tanaka K, Ishikawa T, Takayanagi M: Hepatitis C virus genotypes are not responsible for development of serious liver disease. Dig Dis Sci 1994;39:234-239.
98. Dusheiko G, Schmilovitzweiss H, Brown D, McOmish F, Yap PL, Sherlock S, McIntyre N, Simmonds P: Hepatitis C virus genotypes - An investigation of type-specific differences in geographic origin and disease. Hepatology 1994;19:13-18.
99. Booth JCL, Foster GR, Kumar U, Galassini R, Goldin RD, Brown JL, Thomas HC: Chronic hepatitis C virus infections: Predictive value of genotype and level of viraemia on disease progression and response to interferon alpha. Gut 1995;36:427-432.
100. Kasahara A, Hayashi N, Hiramatsu N, Oshita M, Hagiwara H, Katayama K, Kato M, Masuzawa M, Yoshihara H, Kishida Y, Shimizu Y, Inoue A, Fusamoto H, Kamada T: Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: A multicenter randomized controlled trial. Hepatology 1995;21:291-297.
101. Kobayashi M, Tanaka E, Sodeyama T, Urushihara A, Matsumoto A, Kiyosawa K: The natural course of chronic hepatitis C: A comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology 1996;23:695-699.
102. Takada A, Tsutsumi M, Zhang SC, Okanoue T, Matsushima T, Fujiyama S, Komatsu M: Relationship between hepatocellular carcinoma and subtypes of hepatitis C virus: A nationwide analysis. J Gastroenterol Hepatol 1996;11:166-169.
103. Watson JP, Brind AM, Chapman CE, Bates CL, Gould FK, Johnson SJ, Burt AD, Ferguson J, Simmonds P, Bassendine MF: Hepatitis C virus: Epidemiology and genotypes in the north east of England. Gut 1996;38:269-276.
104. Prati D, Capelli C, Zanella A, Mozzi F, Bosoni P, Pappalettera M, Zanuso F, Vianello L, Locatelli E, DeFazio C, Ronchi G, DelNinno E, Colombo M, Sirchia G: Influence of different hepatitis C virus genotypes on the course of asymptomatic hepatitis C virus infection. Gastroenterology 1996; 110:178-183.
105. Zignego AL, Ferri C, Giannini C, Monti M, Lacivita L, Careccia G, Longombardo G, Lombardini F, Bombardieri S, Gentilini P: Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med 1996;124:31-34.
106. Tsuji H, Shimomura H, Wato M, Kondo J, Tsuji T: Virological and serological characterization of asymptomatic blood donors positive for anti-hepatitis C virus antibody. Acta Med Okayama 1995; 49:1137-144.
107. Yamauchi M, Nakahara M, Nakajima H, Sakamoto K, Hirakawa J, Toda G: Different prevalence of hepatocellular carcinoma between patients with liver cirrhosis due to genotype II and III of hepatitis C virus. Int Hepatol Commun 1994;2:328-332.
108. Chen CH, Sheu JC, Wang JT, Huang GT, yang PM, Lee HS, Lee CZ, Chen DS: Genotypes of hepatitis C virus in chronic liver disease in Taiwan. J Med Virol 1994;44:234-236.
109. Haydon GH, Jarvis LM, Simmonds P, Hayes PC: Association between chronic hepatitis C infection and hepatocellular carcinoma. Lancet 1995;345:928-929.
110. Tanaka K, Ikematsu H, Hirohata T, Kashiwagi S: Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: Possible role of type 1b (II) infection. J Natl Cancer Inst 1996;88:742-746.
111. Yotsuyanagi H, Koike K, Yasuda K, Moriya K, Hino K, Kurokawa K, Iino S: Hepatitis C virus genotypes and development of hepatocellular carcinoma. Cancer 1995;76:1352-1355.
112. Lee DS, Sung YC, Whang YS: Distribution of HCV genotypes among blood donors, patients with chronic liver disease, hepatocellular carcinoma, and patients on maintenance hemodialysis in Korea. J Med Virol 1996;49:55-60.
113. Feray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, Reynes M, Okamoto H, Bismuth H, Brechot C: Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995;108:1088-1096.
114. Gane EJ, Naoumov NV, Qian KP, Mondelli MU, Maertens G, Portmann BC, Lau JYN, Williams R: A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996;110:167-177.
115. Cane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maertens G, Williams R: Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996;334:815-820.
116. Takada N, Takase S, Enomoto N, Takada A, Date T: Clinical backgrounds of the patients having different types of hepatitis C virus genomes. J Hepatol 1992;14:35-40.
117. Horiike N, Masumoto T, Nakanishi K, Michitaka K, Kurose K, Ohkura I, Onji M: Interferon therapy for patients more than 60 years of age with chronic hepatitis C. J Gastroenterol Hepatol 1995;10:246-249.
118. Ideo G, Bellobuono A, Mondazzi L, Tempini S, Bellati G, Ideo GM, Silini E: Alpha interferon treatment in chronic hepatitis C. Clin Exp Rheumatol 1995;13:S167-S173.
119. Chemello L, Bonetti P, Cavalletto L, Talato F, Donadon V, Casarin P, Belussi F, Frezza M, Noventa F, Pontisso P, Benvegnu L, Casarin C, Alberti A, Donada C, Cellini A, Cavinato F, Daquino M, Pozzato G, Terpin M, Urban F, Dabroi G, Macor C, Brosolo P, Pristera G, Cadrobbi P, Crivellaro C, Martinelli S, Dona G: Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. Hepatology 1995;22:700-706.
120. Braconier JH, Paulsen O, Engman K, Widell A: Combined alpha-interferon and ribavirin treatment in chronic hepatitis C: A pilot study. Scand J Infect Dis 1995;27:325-329.
121. Chemello L, Cavalletto L, Bernardinello E, Guido M, pontisso P, Alberti A: The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C. J Hepatol 1995; 23:8-12.
122. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C: Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 1996;334:77-81.
123. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Izumi N, Marumo F, Sato C: Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b - Sensitivity to interferon is conferred by amino acid substitutions in the NS5a region. J Clin Invest 1995;96:224-230.
124. Lau JYN, Simmonds P, Urdea MS: Implications of variations of 'conserved' regions of hepatitis C virus genome. Lancet 1995;346:425-426.
125. Smith DB, Davidson F, Yap PL, Brown H, Kolberg J, Detmer J, Urdea M, Simmonds P, Mellor J, Neville J, Prescott L, Dow BC, Follett EAC, Skuldamrongpanich T, Tanprasert S, Nuchaprayoon C, Lin CK, Kew MC, Crookes R, Conradie JD, Lin M, Seed C, Deolim GAB, Martins IA, Medgyesi GA, Krusius T, Saeed A, Teo D, Lee SH: Levels of hepatitis C virus in blood donors infected with different viral genotypes. J Infect Dis 1996;173:727-730.
126. Hawkins A, Davidson F, Simmonds P: Comparison of plasma virus load amongst individuals infected with hepatitis C virus genotypes 1, 2 and 3 using Quantiplex HCV RNA Assay version 1 and 2, Roche Monitor and an in-house limiting dilution method. J Clin Microbiol, in press.
127. Bell H, Helium K, Harthug S, Maeland A, Ritland S, Myrvang B, von der Lippe B, Raknerud N, Skaug K, Prescott LE, Simmonds P, Construct Group: Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Scand J Infect Dis, in press.
128. Collett MS, Larson R, Gold C, Strick D, Anderson DK, Purchio AF: Molecular cloning and nucleotide sequence of the pestivirus bovine viral diarrhoea virus. Virology 1988;165:191-199.
129. Koonin EV: The phylogeny of RNA-dependent RNA polymerases of positive-strand RNA viruses. J Gen Virol 1991;72:2197-2206.
130. Felsenstein J: PHYLIP Inference Package Version 3.5. Seattle, Department of Genetics, University of Washington, 1993.
131. Sugiyama K, Kato N, Nakazawa T, Yonemura Y, Phornphutkul K, Kunakorn M, Petchclai B, Shimotohno K: Novel genotypes of hepatitis C virus in Thailand. J Gen Virol 1995;76:2323-2327.